查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球基因分型市场：市场规模,份额,趋势分析,技术（PCR,毛细管电泳,微阵列,序列,质谱）,产品,应用,最终用户,地区,细分市场预测2022~2030
市场调查报告书
商品编码
1076684

全球基因分型市场：市场规模,份额,趋势分析,技术（PCR,毛细管电泳,微阵列,序列,质谱）,产品,应用,最终用户,地区,细分市场预测2022~2030

Genotyping Market Size, Share & Trends Analysis Report By Technology (PCR, Capillary Electrophoresis, Microarrays, Sequencing, Mass Spectrometry), By Product, By Application, By End-use, By Region, And Segment Forecasts, 2022 - 2030
出版日期: | 出版商: Grand View Research | 英文 78 Pages | 商品交期: 2-10个工作天内

价格

全球基因分型市场预计在预测期内以 15.6% 的复合年增长率增长，到 2030 年将达到 465 亿美元。

推动市场增长的主要因素包括遗传性疾病患病率增加、对个性化医疗的认识和研究增加，以及基因组学研究的研发资金增加。

本报告调查全球基因分型市场并分析市场概况、市场规模和预测、趋势、增长因素和挑战、客户状况、技术、产品、应用、最终用户和地区，以及竞争形势等。

目录

第一章调查方法及范围

第2章执行摘要

第 3 章基因分型市场变量、趋势和范围

  • 基因分型市场体系展望
  • 渗透率和增长前景映射
  • 监管框架
  • 市场动态
  • 基因分型市场分析工具

第 4 章基因分型市场：竞争分析

  • 主要市场参与者的近期趋势和影响分析
    • 公司/竞争分类（主要创新者、市场领导者、扩张）
    • 重大交易和战略联盟
  • 供应商情况
    • 主要经销商和渠道合作伙伴名单
  • 上市公司
    • 企业市场分析
    • 竞争分析仪表板
  • 私人公司
    • 主要初创企业/技术颠覆者/创新者名单
    • 区域网络图

第 5 章按产品划分的业务分析

  • 基因分型市场：按产品分类的趋势分析
  • 设备
  • 试剂和试剂盒
  • 软件和服务

第6章按用途分析业务

  • 基因分型市场：按应用进行趋势分析
  • 诊断/个体化医疗
  • 药物基因组学
  • 农业生物技术
  • 动物遗传学
  • 其他

第7章技术业务分析

  • 基因分型市场：技术趋势分析
  • 聚合□链反应
  • 毛细管电泳
  • 微阵列
  • 序列
  • 质谱
  • 其他

第 8 章最终用户的业务分析

  • 基因分型市场：最终用户的趋势分析
  • 製药和生物製药公司
  • 诊断研究实验室
  • 学术机构
  • 其他

第9章区域业务分析

  • 基因分型市场：区域趋势分析

第 10 章公司简介

  • 市场参与者的分类
  • 公司简介
Product Code: GVR-1-68038-002-6

Genotyping Market Growth & Trends:

The global genotyping market size is expected to reach USD 46.5 billion by 2030, expanding at a CAGR of 15.6%, according to a new report by Grand View Research Inc. Factors such as the rising prevalence of genetic diseases, rising awareness and research for personalized medicine, and increasing R&D funding for genomics research is expected to contribute to this growth.

Governments in multiple countries are taking various initiatives to provide support and funding to research organizations for personalized medicine, and genotyping research is anticipated to drive the market. For instance, in August 2019, NIH funded USD 4.6 million initial grants to Color, a health technology company, for precision medicine initiatives and development. Similarly, in 2018, the Government of Australia launched the Australian Genomics Health Futures Mission initiative. The government will provide USD 500 million over a period of 10 years for this mission, and the funding will be sourced from Medical Research Future Fund to improve the testing and diagnosis of genetic diseases and for the development of personalized medicine.

An increase in the prevalence of diseases such as cancer, Alzheimer's disease, and Parkinson's disease is another factor that is anticipated to drive demand for genotyping-based diagnostic testing. For instance, Roche has products such as Cobas HCV GT products for cervical cancer diagnosis. Additionally, 23&Me provides genetic testing for medical conditions, such as Parkinson's disease and Alzheimer's disease.

Failed clinical trials cost companies millions of dollars and therefore companies group patients according to their genotypes. Single Nucleotide Polymorphisms (SNP) based genotyping is increasingly being used in pharmacogenomics to study the effect of genetic variations on the difference in response to therapeutics. Genotyping-based treatment administration also helps in overall cost savings.

The COVID-19 pandemic increased the demand for genotyping-based research activities for the development of COVID diagnostics, vaccines, and therapeutics. Many companies, including Qiagen and Thermo Fisher Scientific, have now launched COVID-19 genotyping kits as a result of the growing demand.

Key players leverage strategic partnerships and new product launches to increase their product offerings. For instance, in January 2020, Illumina and Roche entered into a partnership for improving patient access to oncology genomic testing by assay development. Similarly, in June 2021, the Center for Aquaculture Technologies collaborated with Neogen Corporation to provide high-quality genotyping services tailored to aquaculture producers' specific demands.

Genotyping Market Report Highlights:

  • The reagents & kit segment accounted for the largest share of 61.6% in the market in 2021. This is attributed to increased demand for genetic testing, increased R&D spending, and increased genotyping testing volumes
  • PCR segment dominated the market in 2021, whereas sequencing is expected to expand at the highest CAGR during the forecast period. This is due to advantages of the technique, such as low cost per sample, reduced bias as compared to arrays, comparative analysis across samples with no reference genome
  • Pharmacogenomics is estimated to be the fastest-growing application segment during the forecast period due to increased usage of genotyping in drug development to reduce attrition of products in clinical development
  • North America accounted for the largest market share in 2021, owing to proactive government measures, high disease prevalence, technological advancements, and advanced healthcare infrastructure

Table of Contents

Chapter 1. Methodology And Scope

  • 1.1 Market Segmentation
    • 1.1.1 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 Secondary Sources
    • 1.3.3 Primary Research
    • 1.3.4 Details Of Primary Research
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach 1: Commodity Flow Approach
      • 1.6.1.2 Approach 2: Country-Wise Market Estimation Using The Bottom-Up Approach
  • 1.7 Global Market: Cagr Calculation
  • 1.8 Research Assumptions
  • 1.9 List Of Secondary Sources
  • 1.10 List Of Primary Sources
  • 1.11 Objectives
    • 1.11.1 Objective 1:
    • 1.11.2 Objective 2:
  • 1.12 List Of Abbreviations

Chapter 2. Executive Summary

  • 2.1 Market Summary

Chapter 3. Genotyping Market Variables, Trends & Scope

  • 3.1 Genotyping Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
  • 3.2 Penetration & Growth Prospect Mapping
  • 3.3 Regulatory Framework
  • 3.4 Market Dynamics
    • 3.4.1 Market Driver Analysis
      • 3.4.1.1 Rising Prevalence Of Genetic And Other Target Diseases
      • 3.4.1.2 Increasing Focus On The Development Of Targeted Drugs And Personalized Medicine
      • 3.4.1.3 Technological Advancements
      • 3.4.1.4 Increase In Funding In Genomics
    • 3.4.2 Market Restraint Analysis
      • 3.4.2.1 Lack Of Skilled Labor
      • 3.4.2.2 Ambiguous Reimbursement Policies
  • 3.5 Genotyping Market Analysis Tools
    • 3.5.1 Porter's Five Forces Analysis
    • 3.5.2 Swot Analysis; By Factor (Political & Legal, Economic And Technological)

Chapter 4. Genotyping Market - Competitive Analysis

  • 4.1 Recent Developments & Impact Analysis, By Key Market Participants
    • 4.1.1 Company/Competition Categorization (Key Innovators, Market Leaders, Expansion)
    • 4.1.2 Major Deals And Strategic Alliances
  • 4.2 Vendor Landscape
    • 4.2.1 List Of Key Distributors And Channel Partners
    • 4.2.2 Key Company Market Share Analysis, 2021
  • 4.3 Public Companies
    • 4.3.1 Company Market Position Analysis
    • 4.3.2 Competitive Dashboard Analysis
  • 4.4 Private Companies
    • 4.4.1 List Of Key Emerging Companies /Technology Disruptors/Innovators
    • 4.4.2 Regional Network Map

Chapter 5. Product Business Analysis

  • 5.1 Genotyping Market: Product Movement Analysis
  • 5.2 Instruments
    • 5.2.1 Instruments Market, 2018 - 2030 (USD Million)
  • 5.3 Reagents & Kits
    • 5.3.1 Reagents & Kits Market, 2018 - 2030 (USD Million)
  • 5.4 Software & Services
    • 5.4.1 Software & Services Market, 2018 - 2030 (USD Million)

Chapter 6. Application Business Analysis

  • 6.1 Genotyping Market: Application Movement Analysis
  • 6.2 Diagnostics & Personalized Medicine
    • 6.2.1 Diagnostics & Personalized Medicine Market, 2018 - 2030 (USD Million)
  • 6.3 Pharmacogenomics
    • 6.3.1 Pharmacogenomics Market, 2018 - 2030 (USD Million)
  • 6.4 Agricultural Biotechnology
    • 6.4.1 Agricultural Biotechnology Market, 2018 - 2030 (USD Million)
  • 6.3 Animal Genetics
    • 6.3.1 Animal Genetics Market, 2018 - 2030 (USD Million)
  • 6.6 Others
    • 6.6.1 Others Market, 2018 - 2030 (USD Million)

Chapter 7. Technology Business Analysis

  • 7.1 Genotyping Market: Technology Movement Analysis
  • 7.2 Pcr
    • 7.2.1 Pcr Market, 2018 - 2030 (USD Million)
  • 7.3 Capillary Electrophoresis
    • 7.3.1 Capillary Electrophoresis Market, 2018 - 2030 (USD Million)
  • 7.4 Microarrays
    • 7.4.1 Microarrays Market, 2018 - 2030 (USD Million)
  • 7.5 Sequencing
    • 7.5.1 Sequencing Market, 2018 - 2030 (USD Million)
  • 7.6 Mass Spectrometry
    • 7.6.1 Mass Spectrometry Market, 2018 - 2030 (USD Million)
  • 7.7 Others
    • 7.7.1 Others Market, 2018 - 2030 (USD Million)

Chapter 8. End-Use Business Analysis

  • 8.1 Genotyping Market: End-Use Movement Analysis
  • 8.2 Pharmaceutical And Biopharmaceutical Companies
    • 8.2.1 Pharmaceutical And Biopharmaceutical Companies Market, 2018 - 2030 (USD Million)
  • 8.3 Diagnostics And Research Laboratories
    • 8.3.1 Diagnostics And Research Laboratories Market, 2018 - 2030 (USD Million)
  • 8.4 Academic Institutes
    • 8.4.1 Academic Institutes Market, 2018 - 2030 (USD Million)
  • 8.5 Others
    • 8.5.1 Others Market, 2018 - 2030 (USD Million)

Chapter 9. Regional Business Analysis

  • 9.1 Genotyping Market: Regional Movement Analysis
    • 9.1.1 North America
      • 9.1.1.1 North America Market Estimates And Forecast, 2018 - 2030, USD Million
      • 9.1.1.2 U.S.
      • 9.1.1.2.1 U.S. Market Estimates And Forecast, 2018 - 2030, USD Million
      • 9.1.1.3 Canada
      • 9.1.1.3.1 Canada Market Estimates And Forecast, 2018 - 2030, USD Million
    • 9.1.2 Europe
      • 9.1.2.1 Europe Market Estimates And Forecast, 2018 - 2030, USD Million
      • 9.1.2.2 Uk
      • 9.1.2.2.1 Uk Market Estimates And Forecast, 2018 - 2030, USD Million
      • 9.1.2.3 Germany
      • 9.1.2.3.1 Germany Market Estimates And Forecast, 2018 - 2030, USD Million
      • 9.1.2.4 France
      • 9.1.2.4.1 France Market Estimates And Forecast, 2018 - 2030, USD Million
      • 9.1.2.5 Spain
      • 9.1.2.5.1 Spain Market Estimates And Forecast, 2018 - 2030, USD Million
      • 9.1.2.6 Italy
      • 9.1.2.6.1 Italy Market Estimates And Forecast, 2018 - 2030, USD Million
    • 9.1.3 Asia Pacific
      • 9.1.3.1 Asia Pacific Market Estimates And Forecast, 2018 - 2030, USD Million
      • 9.1.3.2 Japan
      • 9.1.3.2.1 Japan Market Estimates And Forecast, 2018 - 2030, USD Million
      • 9.1.3.3 China
      • 9.1.3.3.1 China Market Estimates And Forecast, 2018 - 2030, USD Million
      • 9.1.3.4 India
      • 9.1.3.4.1 India Market Estimates And Forecast, 2018 - 2030, USD Million
      • 9.1.3.5 Australia
      • 9.1.3.5.1 Australia Market Estimates And Forecast, 2018 - 2030, USD Million
      • 9.1.3.6 South Korea
      • 9.1.3.6.1 South Korea Market Estimates And Forecast, 2018 - 2030, USD Million
    • 9.1.4 Latin America
      • 9.1.4.1 Latin America Market Estimates And Forecast, 2018 - 2030, USD Million
      • 9.1.4.2 Brazil
      • 9.1.4.2.1 Brazil Market Estimates And Forecast, 2018 - 2030, USD Million
      • 9.1.4.3 Mexico
      • 9.1.4.3.1 Mexico Market Estimates And Forecast, 2018 - 2030, USD Million
      • 9.1.4.4 Argentina
      • 9.1.4.4.1 Argentina Market Estimates And Forecast, 2018 - 2030, USD Million
    • 9.1.5 Middle East & Africa
      • 9.1.5.1 Middle East & Africa Market Estimates And Forecast, 2018 - 2030, USD Million
      • 9.1.5.2 South Africa
      • 9.1.5.2.1 South Africa Market Estimates And Forecast, 2018 - 2030, USD Million
      • 9.1.5.3 Saudi Arabia
      • 9.1.5.3.1 Saudi Arabia Market Estimates And Forecast, 2018 - 2030, USD Million
      • 9.1.5.5 United Arab Emirates
      • 9.1.5.5.1 United Arab Emirates Market Estimates And Forecast, 2018 - 2030, USD Million

Chapter 10. Company Profile

  • 10.1 Market Participation Categorization
  • 10.2 Company Profiles
    • 10.2.1 Illumina Inc.
      • 10.2.1.1 Company Overview
      • 10.2.1.3 Financial Performance
      • 10.2.1.4 Product Benchmarking
      • 10.2.1.5 Strategic Initiatives
    • 10.2.2 Thermo Fisher Scientific Inc.
      • 10.2.2.1 Company Overview
      • 10.2.2.2 Financial Performance
      • 10.2.2.3 Product Benchmarking
      • 10.2.2.4 Strategic Initiatives
    • 10.2.3 Qiagen Inc.
      • 10.2.3.1 Company Overview
      • 10.2.3.2 Financial Performance
      • 10.2.3.3 Product Benchmarking
      • 10.2.3.4 Strategic Initiatives
    • 10.2.4 F. Hoffman-La Roche Ltd.
      • 10.2.4.1 Company Overview
      • 10.2.4.2 Financial Performance
      • 10.2.4.3 Product Benchmarking
      • 10.2.4.4 Strategic Initiatives
    • 10.2.5 Fluidigm Corporation
      • 10.2.5.1 Company Overview
      • 10.2.5.2 Financial Performance
      • 10.2.5.3 Product Benchmarking
      • 10.2.5.4 Strategic Initiatives
    • 10.2.6 Danaher Corporation
      • 10.2.5.1 Company Overview
      • 10.2.5.2 Financial Performance
      • 10.2.5.3 Product Benchmarking
      • 10.2.5.4 Strategic Initiatives
    • 10.2.7 Agilent Technologies
      • 10.2.7.1 Company Overview
      • 10.2.7.2 Financial Performance
      • 10.2.7.3 Product Benchmarking
      • 10.2.7.4 Strategic Initiatives
    • 10.2.8 Eurofins Scientific Inc.
      • 10.2.8.1 Company Overview
      • 10.2.8.2 Financial Performance
      • 10.2.8.3 Product Benchmarking
      • 10.2.8.4 Strategic Initiatives
    • 10.2.9 Ge Healthcare Inc.
      • 10.2.9.1 Company Overview
      • 10.2.9.2 Financial Performance
      • 10.2.9.3 Product Benchmarking
      • 10.2.9.4 Strategic Initiatives
    • 10.2.10 Bio-Rad Laboratories Inc.
      • 10.2.10.1 Company Overview
      • 10.2.10.2 Financial Performance
      • 10.2.10.3 Product Benchmarking
      • 10.2.10.4 Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of Abbreviations
  • Table 3 North America genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 4 North America genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 5 North America genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 6 North America genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 7 U.S. genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 8 U.S. genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 9 U.S. genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 10 U.S. genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 11 Canada genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 12 Canada genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 13 Canada genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 14 Canada genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 15 Europe genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 16 Europe genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 17 Europe genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 18 Europe genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 19 UK genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 20 UK genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 21 UK genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 22 UK genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 23 Germany genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 24 Germany genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 25 Germany genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 26 Germany genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 27 France genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 28 France genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 29 France genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 30 France genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 31 Italy genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 32 Italy genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 33 Italy genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 34 Italy genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 35 Spain genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 36 Spain genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 37 Spain genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 38 Spain genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 39 Asia Pacific genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 43 Japan genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 44 Japan genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 45 Japan genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 46 Japan genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 47 China genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 48 China genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 49 China genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 50 China genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 51 India genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 52 India genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 53 India genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 54 India genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 55 Australia genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 56 Australia genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 57 Australia genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 58 Australia genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 59 South Korea genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 60 South Korea genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 61 South Korea genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 62 South Korea genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 63 Latin America genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 64 Latin America genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 65 Latin America genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 66 Latin America genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 67 Brazil genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 68 Brazil genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 69 Brazil genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 70 Brazil genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 71 Mexico genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 72 Mexico genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 73 Mexico genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 74 Mexico genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 75 Argentina genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 76 Argentina genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 77 Argentina genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 78 Argentina genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 79 MEA genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 80 MEA genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 81 MEA genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 82 MEA genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 8 South Africa genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 82 South Africa genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 83 South Africa genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 84 South Africa genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 85 Saudi Arabia genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 90 UAE genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 91 UAE genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 92 UAE genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 93 UAE genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 94 List of key distributors

List of Figures

  • Fig. 1 Genotyping market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Genotyping market snapshot
  • Fig. 10 Genotyping market driver impact
  • Fig. 11 Genotyping market restraint impact
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 SWOT analysis, by factor (political & legal economic, and technological)
  • Fig. 14 Porter's five forces analysis
  • Fig. 15 Genotyping market: Product movement analysis
  • Fig. 16 Genotyping product outlook: Key takeaways
  • Fig. 17 Instruments market, 2018 - 2030 (USD million)
  • Fig. 18 Reagents & Kits market, 2018 - 2030 (USD million)
  • Fig. 19 Software & Services market, 2018 - 2030 (USD million)
  • Fig. 20 Genotyping market: Technology movement analysis
  • Fig. 21 Genotyping technology outlook: Key takeaways
  • Fig. 22 PCR market, 2018 - 2030 (USD million)
  • Fig. 23 Capillary Electrophoresis market, 2018 - 2030 (USD million)
  • Fig. 24 Microarrays market, 2018 - 2030 (USD million)
  • Fig. 25 Mass Spectrometry market, 2018 - 2030 (USD million)
  • Fig. 26 Others market, 2018 - 2030 (USD million)
  • Fig. 27 Genotyping market: Application movement analysis
  • Fig. 28 Genotyping application outlook: Key takeaways
  • Fig. 29 Diagnostics & personalized medicine market, 2018 - 2030 (USD million)
  • Fig. 30 Pharmacogenomics market, 2018 - 2030 (USD million)
  • Fig. 31 Agricultural biotechnology market, 2018 - 2030 (USD million)
  • Fig. 32 Animal genetics market, 2018 - 2030 (USD million)
  • Fig. 33 Others market, 2018 - 2030 (USD million)
  • Fig. 34 Genotyping market: End-use movement analysis
  • Fig. 35 Genotyping end-use outlook: Key takeaways
  • Fig. 36 Pharmaceutical and biopharmaceutical companies market, 2018 - 2030 (USD million)
  • Fig. 37 Diagnostics and research laboratories market, 2018 - 2030 (USD million)
  • Fig. 38 Academic institutes market, 2018 - 2030 (USD million)
  • Fig. 39 Others market, 2018 - 2030 (USD million)
  • Fig. 40 Genotyping market: Regional outlook and key takeaways
  • Fig. 41 Genotyping market: Regional movement analysis
  • Fig. 42 North America
  • Fig. 43 North America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 U.S.
  • Fig. 45 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Canada
  • Fig. 47 Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Europe
  • Fig. 49 Europe market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 UK
  • Fig. 51 UK market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Germany
  • Fig. 53 Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Italy
  • Fig. 55 Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Spain
  • Fig. 57 Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 France
  • Fig. 59 France market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Asia Pacific
  • Fig. 61 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Japan
  • Fig. 63 Japan market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 China
  • Fig. 65 China market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 India
  • Fig. 67 India market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 68 Australia
  • Fig. 69 Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 70 South Korea
  • Fig. 71 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 72 Latin America
  • Fig. 73 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 74 Brazil
  • Fig. 75 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 76 Mexico
  • Fig. 77 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 78 Argentina
  • Fig. 79 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 80 Middle East & Africa
  • Fig. 81 Middle East and Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 82 South Africa
  • Fig. 83 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 84 Saudi Arabia
  • Fig. 85 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 86 UAE
  • Fig. 87 UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG.88 Company market share analysis
  • FIG.89 Company market position analysis (Revenue US$ mn)
  • FIG.90 Company market position analysis (Profit Margin)
  • Fig. 91Competitive dashboard analysis
  • Fig. 92 Regional Network Map